【査読付き英文論文】

*1. Gouji Toyokawa, Hyun-Soo Cho, Yukiko Iwai, Masanori Yoshimatsu, Masashi Takawa, Shinya Hayami, Kazuhiro Maejima, Noriaki Shimizu, Hirotoshi Tanaka, Tatsuhiko Tsunoda, Helen I. Field, John D. Kelly, David E. Neal, Bruce A.J. Ponder, Yoshihiko Maehara, Yusuke Nakamura, Ryuji Hamamoto: The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6. Cancer Prevention Research, 4, 2051-2061 (2011)

*2. Gouji Toyokawa, Hyun-Soo Cho, Ken Masuda, Yuka Yamane, Masanori Yoshimatsu, Shinya Hayami, Masashi Takawa, Yukiko Iwai, Yataro Daigo, Eiju Tsuchiya, Tatsuhiko Tsunoda, Helen I. Field, John D. Kelly, David E. Neal, Yoshihiko Maehara, Bruce A.J. Ponder, Yusuke Nakamura, Ryuji Hamamoto: The Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt Pathway. Neoplasia, 13, 887-898 (2011)

*3. Hyun-Soo Cho, John D. Kelly, Shinya Hayami, Gouji Toyokawa, Masahi Takawa, Masanori Yoshimatsu, Tatsuhiko Tsunoda, Helen I. Field, David E. Neal, Bruce A.J. Ponder, Yusuke Nakamura, Ryuji Hamamoto: Enhanced Expression of EHMT2 Is Involved in the Proliferation of Cancer Cells through Negative Regulation of SIAH1. Neoplasia, 13, 676-684 (2011)

*4. Gouji Toyokawa, Ken Masuda, Yataro Daigo, Hyun-Soo Cho, Masanori Yoshimatsu, Masashi Takawa, Shinya Hayami, Kazuhiro Maejima, Makoto Chino, Helen I. Field, David E. Neal, Eijyu Tsuchiya, Bruce A.J. Ponder, Yoshihiko Maehara, Yusuke Nakamura, Ryuji Hamamoto: Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. Molecular Cancer, 10, 65 (2011)

*5. Masashi Takawa, Ken Masuda, Masaki Kunizaki, Yataro Daigo, Katsunori Takagi, Yukiko Iwai, Hyun-Soo Cho, Gouji Toyokawa, Yuka Yamane, Kazuhiro Maejima, Helen I. Field, Takaaki Kobayashi, Takayuki Akasu, Masanori Sugiyama, Eijyu Tsuchiya, Yutaka Atomi, Bruce A.J. Ponder, Yusuke Nakamura, Ryuji Hamamoto: Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Science, 102, 1298-1305 (2011)

*6. Hyun-Soo Cho, Takehiro Suzuki, Naoshi Dohmae, Shinya Hayami, Motoko Unoki, Masanori Yoshimatsu, Gouji Toyokawa, Masashi Takawa, Taiping Chen, Julia K. Kurash, Helen I. Field, Bruce A.J. Ponder, Yusuke Nakamura, Ryuji Hamamoto: Demethylation of MYPT1 by LSD1 promotes cell cycle progression in cancer cells. Cancer Research, 71, 1-6 (2011)

*7. Masanori Yoshimatsu, Gouji Toyokawa, Shinya Hayami, Motoko Unoki, Tatsuhiko Tsunoda, Helen I. Field, John D. Kelly, David E. Neal, Yoshihiko Maehara, Bruce A.J. Ponder, Yusuke Nakamura, Ryuji Hamamoto: Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers. International Journal of Cancer, 128, 562-573 (2011)

*8. Shinya Hayami, John D. Kelly, Hyun-Soo Cho, Masanori Yoshimatsu, Motoko Unoki, Tatsuhiko Tsunoda, Helen I. Field, David E. Neal, Hiroki Yamaue, Bruce A.J. Ponder, Yusuke Nakamura, Ryuji Hamamoto: Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. International Journal of Cancer, 128, 574-586 (2011)